SCHEMBL3429910

SCHEMBL3429910

Nc1ccccc1C(=O)N1CCN(c2cccnn2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.62
NAMPT P43490 1/20 0.52
ALDH1A1 P00352 7/20 0.51
HSD17B10 Q99714 3/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HPGD P15428 2/20 0.51
TSHR P16473 3/20 0.49
LMNA P02545 2/20 0.49
GAA P10253 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
TRPV1 Q8NER1 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3432771 0.83 SLC6A7 (0.57) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL2007249 0.81 SCD (0.61) SLC6A7
SCHEMBL3408927 0.81 SLC6A7 (0.58) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL3430705 0.80 SLC6A7 (0.57) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL938368 0.80 SCD (0.53) ALDH1A1MEN1KMT2ATSHRCA12
SCHEMBL10663590 0.80 CA12 (0.67) ALDH1A1MEN1KMT2ATSHRLMNA
SCHEMBL27702525 0.78 SLC6A7 (0.63) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL3432265 0.78 SLC6A7 (0.55) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL3434504 0.78 GAA (0.56) SLC6A7NAMPTALDH1A1HSD17B10KDM4E
SCHEMBL4813898 0.77 SLC6A7 (0.66) SLC6A7NAMPTALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257291-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS Xenon Pharmaceuticals Inc. (CA) 2010-12-08 EP disclosed
WO-2009106991-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2009-09-03 WO disclosed